Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
about
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.Fertility issues in cancer survivorship.Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.Sexual Health, Mental Health, and Beliefs About Cancer Treatments Among Women Attending a Gynecologic Oncology Clinic.
P2860
Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
@en
Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
@nl
type
label
Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
@en
Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
@nl
prefLabel
Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
@en
Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
@nl
P2860
P1476
Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.
@en
P2093
Lino Del Pup
P2860
P304
P356
10.3109/09513590.2011.652717
P577
2012-03-12T00:00:00Z